23.5 C
New York
Thursday, July 3, 2025

Tag: APIs

Lightchain AI Launches Final Bonus Phase After Raising $21.1M Ahead of July 2025 Mainnet Launch

SHREWSBURY, United Kingdom, July 02, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, an AI-native decentralized infrastructure platform, today announced the start of its Final Bonus Phase, following the successful completion of all 15 presale stages and the achievement of a major milestone—$21.1 million raised from a global community of early contributors. This final round offers a fixed price of $0.007125 per LCAI token, providing one last opportunity for participants ahead of the mainnet launch scheduled for July 2025.

Lightchain AI Announces Final Token Distribution Round Prior to Mainnet Activation

SHREWSBURY, United Kingdom, July 01, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, the AI-native blockchain infrastructure platform, has entered its Bonus Round after successfully completing 15 presale stages and raising more than $21.1 million from early supporters. The Bonus Round is now live at a fixed token price of $0.007125, marking the final opportunity for contributors to access Lightchain AI tokens before the mainnet launch scheduled for July 2025.

AI on the Frontline: Global Firms Back Innovation, Brace for New Cyber Threats

New Trend Micro research reveals widespread AI adoption in cybersecurity strategies, but mounting concerns cyber risk exposure DALLAS, July 1, 2025 /PRNewswire/ -- Global AI cybersecurity...

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

Sales Order Management & Collaboration from Elemica® Achieves SAP® Certified Integration with RISE with SAP S/4HANA® Cloud 

WAYNE, Pa., June 25, 2025 (GLOBE NEWSWIRE) -- Elemica, the leader in network-based digital supply chain management and provider of the premier multi-enterprise digital supply chain network for all companies buying, selling and servicing the process manufacturing industry, today announced that its Sales Order Management & Collaboration solution has achieved SAP® certification as integrated with RISE with SAP S/4HANA® Cloud. This integration helps organizations to more efficiently use Elemica’s Sales Order Management & Collaboration solution before, during and after their SAP S/4HANA migration.   

Generative AI Services Market to Hit USD 43.8 Billion by 2030, Fueled by SaaS & Healthcare Demand | Valuates Reports

Generative AI Services Market is Segmented by Type (IaaS, PaaS, SaaS), by Application (Marketing and Advertising, Technology, Consulting, Teaching, Accounting, Healthcare). BANGALORE, India, June 24,...

Vyne Dental Expands Commitment to Interoperability With Open Dental Software Integration Agreement

New API agreement reinforces Vyne Dental's commitment to driving practical, standards-based interoperability across the dental industry. INDIANAPOLIS, June 24, 2025 /PRNewswire/ -- Vyne Dental®, a leading...

EMR June 2025 highlights growing monetization appeal of 5G fixed wireless access

More than half of all service providers globally who offer fixed wireless access now do so with speed-based monetization benefits enhanced by 5G5G subscriptions...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAPIs